Barrie Urology Group

With technological advancements, Unmanned Aerial Vehicles (UAVs) are becoming prominent in next-generation wireless networks because they enable rapid deployment, enhance coverage, and provide advanced services to end users. End users benefit significantly from offloading complex and computationally demanding tasks to flying platforms made possible by UAVs outfitted with edge computing servers. However, attaining optimal and effective network performance depends on proper resource management. The capabilities of next-generation networks are increased through the integration of UAV-assisted Mobile Edge Computing with current wireless infrastructure. In recent era, Internet of Things (IoT) devices are frequently used for real-time data monitoring, gathering, analysis, and transmission for decision-making. This paper presents an optimization problem to increase the number of IoT devices UAVs can serve while minimizing latency and resource costs related to communication, computing, caching, and energy harvesting. We developed a robust offloading strategy that dynamically adapts to IoT spatial perturbations, ensuring efficient workload distribution and minimizing latency. Additionally we integrated Digital Twin technology, allowing thorough network replication and monitoring to analyse latency. A complex mixed-integer nonlinear programming problem has been formulated. We provide a multi-stage offloading mechanism called the Integrality Gap Method with an Interior Point mechanism to tackle this complexity. Simulation findings show that the suggested approach performs better than the straightforward relaxation heuristic technique, confirming its effectiveness.

We present data from the TRuE-V1/TRuE-V2 rollover TRuE-V long-term extension study evaluating withdrawal and continuation of ruxolitinib cream treatment. Among patients with near-complete facial repigmentation in TRuE-V1/TRuE-V2, approximately 70% of those randomized to treatment continuation and approximately 40% of those randomized to treatment withdrawal maintained facial repigmentation indicative of treatment success (i.e. ≥ F-VASI 75). Lost repigmentation could be regained in a timely manner following reinitiation of open-label active treatment.

Over the past decade, the role and expectations of police officers has undergone significant transformation. Challenges such as social media, societal pressures, officer fatigue, and increasingly sophisticated and lethal criminal activities have made the job more difficult. Specifically, police ambushes and targeted attacks have created a divide between officers and the communities they serve, often resulting in moral injury and mental health issues for officers. From a leadership perspective, ambushes have caused emotional distress, a situation that is becoming more frequent in Canada. The progression in crisis support practices has been slow, with many services still using Critical Incident Stress Debriefing, a program with questionable effectiveness and safety. An alternative strategy involves peer teams that are trained in clinical intervention techniques and have access to an external clinical psychology team. This setup offers peer team members the necessary support and guidance when assisting colleagues in distress. This trauma-informed approach, which considers the needs of individual officers while delivering quick and effective intervention, can reduce the impact of critical incidents on officer mental health.

IntroductionHidradenitis suppurativa (HS) is a chronic, painful skin disease associated with a high disease burden. Disease-related pain is frequently reported as the most troublesome symptom of HS. The SUNSHINE and SUNRISE phase 3 trials previously reported that secukinumab improved control of pain in patients with moderate to severe HS. The objective of this analysis was to evaluate the impact of secukinumab on multiple aspects of pain in patients with HS from SUNSHINE and SUNRISE.MethodsPatients were randomised to receive secukinumab 300 mg every 2 (SECQ2W) or 4 weeks (SECQ4W), or placebo until week 16. At week 16, the placebo group switched to receive SECQ2W (placebo-SECQ2W) or SECQ4W (placebo-SECQ4W), whereas the secukinumab groups continued their treatment, until week 52. Pain was assessed using the Patient’s Global Assessment of skin pain‒at worst on a continuous numeric rating scale (NRS) through week 52. Quartiles were used to categorise pain severity groups based on baseline NRS scores (NRS ≤ 3.3; NRS > 3.3 to ≤ 5.4; NRS > 5.4 to ≤ 7.2; NRS > 7.2). Additional assessments included quality of life (QoL) and pain medication use.ResultsAt week 16, a greater mean (standard deviation) absolute change from baseline in skin pain was observed for patients treated with secukinumab [SECQ2W (− 1.35 (2.16)); SECQ4W (− 1.05 (2.02))] versus placebo [− 0.47 (2.07)]. In the SECQ2W and SECQ4W groups, in patients with NRS > 7.2 at baseline, 20.0% and 12.7% had NRS ≤ 3.3 at week 16, respectively. This improvement in pain was maintained through week 52. Moreover, patients in the NRS ≤ 3.3 category generally experienced better QoL. The proportion of patients reporting pain medication use was generally reduced at weeks 16 and 52 versus baseline in the secukinumab groups.ConclusionThis analysis highlights the sustained benefits of secukinumab in reducing pain in patients with moderate to severe HS. These pain reductions were associated with QoL improvements.Trial RegistrationClinicalTrials.gov identifier: NCT03713619 (SUNSHINE) and NCT03713632 (SUNRISE).Supplementary InformationThe online version contains supplementary material available at 10.1007/s13555-025-01426-x.

This brief report presents updated findings from the previously published CREST study evaluating the safety and effectiveness of 8-week glecaprevir/pibrentasvir (GLE/PIB) in treatment-naïve patients with chronic hepatitisC virus (HCV) infection and compensated cirrhosis. The current study includes an additional 51 patients, presents effectiveness data stratified by additional comorbidities and comedications, and offers insights into healthcare resource utilization. Analysis of treatment-naïve patients with HCV infection and compensated cirrhosis enrolled in the CREST study, a real-world, observational multicenter study. All enrolled patients were included in the full analysis set (FAS); the modified analysis set (MAS) excluded patients with missing SVR12 data, or who discontinued GLE/PIB for nonvirologic failure. The primary endpoint was sustained virologic response at posttreatment week12 (SVR12) in the MAS. Safety and healthcare resource utilization were also assessed. The FAS included 437 patients, and the MAS 375. Overall, the results were consistent with the previously published study, with 98.9% of patients in the MAS achieving SVR12. Patients with comorbidities such as alcoholism, diabetes, and hyperlipidemia achieved SVR12 rates > 94%. High SVR12 rates were also achieved by patients receiving comedications such as anxiolytics, antidepressants, and opioid agonists. Of the 26.8% of patients with an adverse event, 1.1% had a serious adverse event, none of which were deemed related to GLE/PIB. Healthcare resource utilization varied by employment status and history of drug use. Active drug users had more physician and nurse visits than specialist visits compared with former drug users. This study provides further evidence on the safety and effectiveness of 8-week GLE/PIB, supporting the use of shorter treatment in treatment-naïve patients with Child-PughA cirrhosis including subgroups of interest, regardless of comorbidities and comedications observed in this population. The variable healthcare resource utilization in different patient types can help plan and resource linkage to care better, thus supporting HCV elimination efforts.

Police officers experience higher levels of mental illness compared to the general population. These traumas are known as operational stress injuries and are the result of operational and organizational stressors. These stressors often result in elevated levels of stress, anxiety, and depression. Mindfulness is widely becoming a mainstream method to help individuals cope with these disorders; however, while rapidly growing, the literature on the efficacy of mindfulness programs for police officers is in its infancy. Given the atypical work schedules officers keep, and the COVID-driven demand for remote service delivery, this pilot study examined the efficacy of a modified version of the online mindfulness program called MindFit Cop. Officers in our study completed a series of surveys before and after the 9-week intervention. We found significant results across timepoints for total mindfulness and self-compassion scores, and a significant interaction for time × group for non-reactivity. No significant results were found for group. This pilot study lends further support for the benefits of mindfulness for police officers in improving overall mindfulness and self-compassion.

We compared experiences of patients who reported usually being seen by a resident with those usually seen by a staff physician. We analyzed responses to a patient experience survey distributed at 13 family medicine teaching practices affiliated with the University of Toronto between May and June 2020. We analyzed responses to seven questions pertaining to timely access, continuity, and patient-centeredness. We compared responses between two types of usual primary care clinicians and calculated odds ratios before and after adjustment for patient characteristics. We analyzed data from 6,545 unique surveys; 18.6% reported their usual clinician was a resident physician. Resident patients were more likely to be older, born outside of Canada, report a high school education or less, and report having difficulty making ends meet. Compared to patients of staff physicians, patients of resident physicians had lower odds of being able to see their preferred primary care clinician and lower odds of getting nonurgent care in a reasonable time. They also had lower odds of reporting patient-centered care, but we found no significant differences in whether the time for an urgent appointment was about right or whether accessing care after hours was easy. In our setting, patients who reported usually seeing resident physicians had worse continuity of care and timeliness for nonurgent care than patients who reported usually seeing staff physicians despite resident patients being older, sicker, and having a lower socioeconomic position. Postgraduate training programs need to test models to support access and continuity for resident patient panels.

We report outcomes following spine stereotactic body radiotherapy (SBRT) in metastatic non-small cell lung cancer (NSCLC) and the significance of programmed death-ligand 1 (PD-L1) status, epidermal growth factor receptor (EGFR) mutation and timing of immune check point inhibitors (ICI) on local failure (LF). 165 patients and 389 spinal segments were retrospectively reviewed from 2009 to 2021. Baseline patient characteristics, treatment and outcomes were abstracted. Primary endpoint was LF and secondary, overall survival (OS) and vertebral compression fracture (VCF). Multivariable analysis (MVA) evaluated factors predictive of LF and VCF. The median follow-up and OS were: 13.0months (range, 0.5-95.3months) and 18.4months (95% CI 11.4-24.6). 52.1% were male and 76.4% had adenocarcinoma. Of the 389 segments, 30.3% harboured an EGFR mutation and 17.0% were PD-L1 ≥ 50%. The 24months LF rate in PD-L1 ≥ 50% vs PD-L1 < 50% was 10.7% vs. 38.0%, and in EGFR-positive vs. negative was 18.1% vs. 30.0%. On MVA, PD-L1 status of ≥ 50% (HR 0.32, 95% CI 0.15-0.69, p = 0.004) significantly predicted for lower LF compared to PD-L1 < 50%. Lower LF trend was seen with ICI administration peri and post SBRT (HR 0.41, 95% CI 0.16-1.05, p = 0.062). On MVA, polymetastatic disease (HR 3.28, 95% CI 1.84-5.85, p < 0.0001) and ECOG ≥ 2 (HR 1.87, 95% CI 1.16-3.02, p = 0.011) significantly predicted for worse OS and absence of baseline VCF predicted for lower VCF rate (HR 0.20, 95% CI 0.10-0.39, p < 0.0001). We report a significant association of PD-L1 ≥ 50% status on improved LC rates from spine SBRT in NSCLC patients.